Fanrong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fanrong Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ning Zhou
Department of Pathology, Mianyang 404 Hospital, Mianyang, Sichuan, China
2 shared publications - Shuya Hu
Department of Pathology, Mianyang 404 Hospital, Mianyang, Sichuan, China
2 shared publications - Hegang Wu
Department of Pathology, The First People’s Hospital of Yibin, Yibin, Sichuan, China
1 shared publication Jiamin Qin
Department of Gastroenterology, Sichuan Mianyang 404 Hospital, Mianyang City, Sichuan Province, China
1 shared publication- Liansong Ye
Department of Gastroenterology and Hepatology, Sichuan University West China Hospital, Chengdu, China
1 shared publication - Liming Wen
Department of Gastroenterology, the Affiliated Hospital of Southwest Medical University
1 shared publication
Latest Publications
- Open Access
- 29 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (22) , e48875
Reevaluating the nature of thymic lipofibroadenoma: A case report with hamartomatous features and a literature review
Rationale: Thymic lipofibroadenoma (LFA) is an extremely rare benign thymic tumor of mixed epithelial and mesenchymal origin, whose pathological nature remains incompletely understood. This case presents a unique thymic lesion combining classic LFA features with a novel lobulated, ductal-forming epithelial proliferation, prompting a reevaluation of its classification. Patient concerns: A 68-year-old male nonsmoker with a 10-year history of hypertension was admitted following a motor vehicle accident. Chest computed tomography incidentally revealed a well-circumscribed, heterogeneous mass (55 × 38 × 65 mm) in the right anterior mediastinum, containing both soft-tissue and adipose components. The patient had no specific symptoms related to the mass. Diagnoses: Histological examination showed a biphasic architecture: areas resembling classic thymic LFA with anastomosing bland epithelial strands within a fibroadipose stroma, and a novel component with lobulated hyperplastic epithelium exhibiting ductal differentiation and bilayered glandular structures. Immunohistochemically, epithelial cells were diffusely positive for CK5/6 and p63; ductal structures showed a bilayered pattern (CK7+/p63− luminal cells; p63+ basal cells). The Ki-67 proliferation index was low (<2%). No cytologic atypia, mitosis, or necrosis was seen. Based on the composite hamartomatous morphology, the lesion was diagnosed as a thymic hamartoma. Interventions: The tumor was completely excised via a transxiphoid single-port thoracoscopic approach. The postoperative recovery was uneventful. Outcomes: At 21-month follow-up, the patient remained disease-free with no evidence of recurrence or residual disease on radiographic imaging. Lessons: This unique thymic lesion, featuring LFA-like areas admixed with duct-forming lobulated epithelial proliferation, is best classified as a thymic hamartoma. Review of the literature suggests that previously reported LFAs may also represent hamartomatous lesions rather than true neoplasms. Complete surgical resection appears curative. Further case accumulation and molecular studies are needed to elucidate the pathogenesis.
- 29 May 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (22) , e48875
Open AccessReevaluating the nature of thymic lipofibroadenoma: A case report with hamartomatous features and a literature review
Rationale: Thymic lipofibroadenoma (LFA) is an extremely rare benign thymic tumor of mixed epithelial and mesenchymal origin, whose pathological nature remains incompletely understood. This case presents a unique thymic lesion combining classic LFA features with a novel lobulated, ductal-forming epithelial proliferation, prompting a reevaluation of its classification. Patient concerns: A 68-year-old male nonsmoker with a 10-year history of hypertension was admitted following a motor vehicle accident. Chest computed tomography incidentally revealed a well-circumscribed, heterogeneous mass (55 × 38 × 65 mm) in the right anterior mediastinum, containing both soft-tissue and adipose components. The patient had no specific symptoms related to the mass. Diagnoses: Histological examination showed a biphasic architecture: areas resembling classic thymic LFA with anastomosing bland epithelial strands within a fibroadipose stroma, and a novel component with lobulated hyperplastic epithelium exhibiting ductal differentiation and bilayered glandular structures. Immunohistochemically, epithelial cells were diffusely positive for CK5/6 and p63; ductal structures showed a bilayered pattern (CK7+/p63− luminal cells; p63+ basal cells). The Ki-67 proliferation index was low (<2%). No cytologic atypia, mitosis, or necrosis was seen. Based on the composite hamartomatous morphology, the lesion was diagnosed as a thymic hamartoma. Interventions: The tumor was completely excised via a transxiphoid single-port thoracoscopic approach. The postoperative recovery was uneventful. Outcomes: At 21-month follow-up, the patient remained disease-free with no evidence of recurrence or residual disease on radiographic imaging. Lessons: This unique thymic lesion, featuring LFA-like areas admixed with duct-forming lobulated epithelial proliferation, is best classified as a thymic hamartoma. Review of the literature suggests that previously reported LFAs may also represent hamartomatous lesions rather than true neoplasms. Complete surgical resection appears curative. Further case accumulation and molecular studies are needed to elucidate the pathogenesis.
- 17 November 2023
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (3) , 410
Gastric Signet-Ring Cell Carcinoma With Multiple Colorectal Metastases
An abstract is unavailable. This article is available as a PDF only.
- 17 November 2023
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (3) , 410
Gastric Signet-Ring Cell Carcinoma With Multiple Colorectal Metastases
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 23 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (25) , e34101
Hyalinising clear cell carcinoma of the lung: A case report and review of literature
Background: Hyalinising clear cell carcinoma (HCCC) of the lung is a rare tumor, with only 12 reported cases. To improve the differential diagnosis, the aim of this study was to clarify the clinicopathological characteristics, immunophenotype, and molecular characteristics of HCCC of the lung and relate these to prognosis. Methods: Sections of HCCC of the lung were collected from a patient for pathological observation, immunohistochemistry, histochemistry, and fluorescence in situ hybridization; the clinical, pathological, and molecular characteristics were compared with those reported in the literature. Results: The tumor had a well-demarcated border nodule with a maximal diameter of 2.5 cm. Microscopic findings showed either clear or eosinophilic cytoplasm in the tumor cells. Growth was predominantly in the sheets, nests, and trabeculae in a background of hyalinised, fibrotic stroma, and mucus degeneration. Immunohistochemistry showed that the tumor cells expressed cytokeratin 7, P63, P40, CK5/6, Pan Cytokeratin (PCK), and epithelial membrane antigen, whereas they were negative for thyroid transcription factor-1, napsin A, CD10, vimentin, and smooth muscle actin. The Ki67 proliferation index was 5%. The tumor was positive for both period acid–Schiff (PAS) and Alcian blue–PAS, with a small amount of mucus staining positive for PAS–diastase. Fluorescence in situ hybridization revealed Ewing sarcoma breakpoint region 1 rearrangement and Ewing sarcoma breakpoint region 1-activating transcription factor 1 fusion. Conclusions: HCCC is a low-grade carcinoma with excellent prognosis. Tumour necrosis may be a potential risk factor for recurrence and metastasis. Our review of reported cases suggests that regional lymph node dissection combined with lobectomy is a safer treatment than only lobectomy for HCCC of the lung.
- 23 June 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (25) , e34101
Open AccessHyalinising clear cell carcinoma of the lung: A case report and review of literature
Background: Hyalinising clear cell carcinoma (HCCC) of the lung is a rare tumor, with only 12 reported cases. To improve the differential diagnosis, the aim of this study was to clarify the clinicopathological characteristics, immunophenotype, and molecular characteristics of HCCC of the lung and relate these to prognosis. Methods: Sections of HCCC of the lung were collected from a patient for pathological observation, immunohistochemistry, histochemistry, and fluorescence in situ hybridization; the clinical, pathological, and molecular characteristics were compared with those reported in the literature. Results: The tumor had a well-demarcated border nodule with a maximal diameter of 2.5 cm. Microscopic findings showed either clear or eosinophilic cytoplasm in the tumor cells. Growth was predominantly in the sheets, nests, and trabeculae in a background of hyalinised, fibrotic stroma, and mucus degeneration. Immunohistochemistry showed that the tumor cells expressed cytokeratin 7, P63, P40, CK5/6, Pan Cytokeratin (PCK), and epithelial membrane antigen, whereas they were negative for thyroid transcription factor-1, napsin A, CD10, vimentin, and smooth muscle actin. The Ki67 proliferation index was 5%. The tumor was positive for both period acid–Schiff (PAS) and Alcian blue–PAS, with a small amount of mucus staining positive for PAS–diastase. Fluorescence in situ hybridization revealed Ewing sarcoma breakpoint region 1 rearrangement and Ewing sarcoma breakpoint region 1-activating transcription factor 1 fusion. Conclusions: HCCC is a low-grade carcinoma with excellent prognosis. Tumour necrosis may be a potential risk factor for recurrence and metastasis. Our review of reported cases suggests that regional lymph node dissection combined with lobectomy is a safer treatment than only lobectomy for HCCC of the lung.